Lonza Group Ag - 17 Year Stock Price History | LZAGY
Historical daily share price chart and data for Lonza Group Ag since 2008 adjusted for splits and dividends. The latest closing stock price for Lonza Group Ag as of May 21, 2025 is 67.82.
- The all-time high Lonza Group Ag stock closing price was 83.00 on August 27, 2021.
- The Lonza Group Ag 52-week high stock price is 72.98, which is 7.6% above the current share price.
- The Lonza Group Ag 52-week low stock price is 52.84, which is 22.1% below the current share price.
- The average Lonza Group Ag stock price for the last 52 weeks is 62.24.
| Lonza Group Ag Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2025 | 64.4799 | 58.4604 | 72.3987 | 55.8983 | 67.8200 | 15.42% |
| 2024 | 57.0406 | 41.0934 | 66.7856 | 39.9576 | 58.7575 | 41.80% |
| 2023 | 52.8529 | 48.1738 | 64.8672 | 34.0555 | 41.4355 | -13.69% |
| 2022 | 57.2863 | 79.4947 | 79.4947 | 43.5421 | 48.0052 | -41.08% |
| 2021 | 69.8058 | 62.4007 | 82.9988 | 54.3508 | 81.4753 | 30.57% |
| 2020 | 50.9391 | 35.2290 | 66.5833 | 31.8527 | 62.4017 | 77.00% |
| 2019 | 31.1414 | 24.6842 | 35.3025 | 24.6842 | 35.2561 | 42.46% |
| 2018 | 27.1811 | 25.6509 | 33.2676 | 21.6967 | 24.7484 | -3.29% |
| 2017 | 20.1638 | 13.8270 | 26.0790 | 13.8270 | 25.5903 | 83.43% |
| 2016 | 13.7868 | 12.5840 | 15.8152 | 11.0327 | 13.9509 | 8.29% |
| 2015 | 10.7839 | 8.6953 | 13.0228 | 8.3383 | 12.8828 | 47.34% |
| 2014 | 8.3274 | 7.0778 | 9.7282 | 6.9934 | 8.7433 | 21.96% |
| 2013 | 5.6264 | 3.9145 | 7.1923 | 3.9145 | 7.1689 | 83.44% |
| 2012 | 3.4613 | 4.2750 | 4.5446 | 2.4746 | 3.9080 | -4.01% |
| 2011 | 4.9821 | 5.3654 | 6.0359 | 3.8106 | 4.0713 | -23.44% |
| 2010 | 5.1759 | 4.9042 | 6.2934 | 4.1615 | 5.3180 | 16.47% |
| 2009 | 6.1186 | 6.0220 | 7.1546 | 4.3904 | 4.5660 | -20.34% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $49.059B | $7.468B |
| Lonza Group AG operates as a supplier to the pharmaceutical, healthcare and life-science industries. The Company divides its activities into four divisions: Life Science Ingredients; Microbial Control; Custom Manufacturing, and Bioscience. The company's Life Science Ingredients segment produces nutrition ingredients for applications in nutrition (food, feed and pharmaceutical application) and chemical intermediates for the agricultural industry. The Microbial Control division focuses on five areas: hygiene, wood protection, water treatment, oil/gas applications, and industrial preservation and comprises products ranging from disinfectants to household cleaning products. The Custom Manufacturing division comprises products used in pharmaceuticals sector. The Bioscience division comprises bioscience products, including cell culture and molecular biology tools for research, tests for microbial detection, and media used in the production of therapeutics. Lonza Group AG is headquartered in Basel, Switzerland. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $231.485B | 27.83 |
| Boston Scientific (BSX) | United States | $154.809B | 38.76 |
| Stryker (SYK) | United States | $144.946B | 30.31 |
| EssilorLuxottica (ESLOY) | France | $134.105B | 0.00 |
| Medtronic (MDT) | Ireland | $108.260B | 15.35 |
| Haleon (HLN) | United Kingdom | $50.025B | 28.46 |
| ResMed (RMD) | United States | $36.038B | 27.07 |
| GE HealthCare Technologies (GEHC) | United States | $31.860B | 15.13 |
| Agilent Technologies (A) | United States | $31.051B | 20.51 |
| Terumo (TRUMY) | Japan | $27.450B | 35.65 |
| Insulet (PODD) | United States | $22.837B | 89.64 |
| Koninklijke Philips (PHG) | Netherlands | $22.023B | 15.83 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.348B | 11.78 |
| Baxter (BAX) | United States | $15.616B | 11.66 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.578B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.637B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.204B | 21.59 |
| Lantheus Holdings (LNTH) | United States | $5.198B | 13.11 |
| Prestige Consumer Healthcare (PBH) | United States | $4.172B | 18.64 |
| Perrigo (PRGO) | Ireland | $3.700B | 9.38 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.362B | 14.64 |
| ICU Medical (ICUI) | United States | $3.218B | 23.73 |
| Envista Holdings (NVST) | United States | $2.820B | 23.44 |
| GN Store Nord (GNNDY) | Denmark | $2.097B | 17.37 |
| QuidelOrtho (QDEL) | United States | $2.000B | 13.76 |
| LeMaitre Vascular (LMAT) | United States | $1.841B | 41.16 |
| AtriCure (ATRC) | United States | $1.647B | 0.00 |
| Neogen (NEOG) | United States | $1.350B | 17.28 |
| Acuren (TIC) | United States | $1.305B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.223B | 12.41 |
| Kestra Medical Technologies (KMTS) | United States | $1.186B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.169B | 26.29 |
| BioLife Solutions (BLFS) | United States | $1.049B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.942B | 12.05 |
| InMode (INMD) | Israel | $0.898B | 9.05 |
| CeriBell (CBLL) | United States | $0.634B | 0.00 |
| Evolus (EOLS) | United States | $0.618B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.573B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.554B | 0.00 |
| Owens & Minor (OMI) | United States | $0.531B | 4.40 |
| Valneva SE (VALN) | France | $0.527B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.508B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.436B | 0.00 |
| Surmodics (SRDX) | United States | $0.416B | 0.00 |
| SNDL (SNDL) | Canada | $0.344B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.338B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.331B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.329B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.315B | 11.58 |
| Aurora Cannabis (ACB) | Canada | $0.293B | 52.20 |
| Sanara MedTech (SMTI) | United States | $0.276B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.267B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.264B | 22.23 |
| Verano Holdings (VRNOF) | United States | $0.244B | 0.00 |
| Cerus (CERS) | United States | $0.239B | 0.00 |
| ZimVie (ZIMV) | United States | $0.237B | 10.78 |
| Biote (BTMD) | United States | $0.212B | 5.95 |
| Brainsway (BWAY) | Israel | $0.196B | 52.00 |
| OraSure Technologies (OSUR) | United States | $0.190B | 0.00 |
| Quanterix (QTRX) | United States | $0.187B | 0.00 |
| High Tide (HITI) | Canada | $0.186B | 0.00 |
| Omeros (OMER) | United States | $0.182B | 0.00 |
| Organigram Global (OGI) | Canada | $0.179B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.176B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.173B | 14.11 |
| FitLife Brands (FTLF) | United States | $0.131B | 16.07 |
| Jin Medical (ZJYL) | China | $0.125B | 0.00 |
| Exagen (XGN) | United States | $0.123B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.113B | 0.00 |
| Agape ATP (ATPC) | $0.105B | 0.00 | |
| MacroGenics (MGNX) | United States | $0.094B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.086B | 0.00 |
| Fonar (FONR) | United States | $0.085B | 10.96 |
| Quipt Home Medical (QIPT) | United States | $0.084B | 0.00 |
| InterCure (INCR) | Israel | $0.072B | 0.00 |
| Veru (VERU) | United States | $0.072B | 0.00 |
| Zynex (ZYXI) | United States | $0.069B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.066B | 0.00 |
| Apyx Medical (APYX) | United States | $0.056B | 0.00 |
| ImmuCell (ICCC) | United States | $0.055B | 0.00 |
| United Health Products (UEEC) | United States | $0.055B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.054B | 0.00 |
| United-Guardian (UG) | United States | $0.039B | 13.44 |
| Modular Medical (MODD) | United States | $0.035B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.034B | 0.00 |
| Safety Shot (SHOT) | United States | $0.029B | 0.00 |
| Nephros (NEPH) | United States | $0.024B | 32.29 |
| Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.018B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |